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Background: Intracellular aggregation of polyglutamine (polyQ) proteins can be prevented by the chaperones DNAJB6 and
DNAJB8.
Results: DNAJB6 and DNAJB8 prevent the aggregation of pure polyQ peptides.
Conclusion: The polyQ tract is sufficient for DNAJB6 and DNAJB8 to prevent aggregation.
Significance: By interacting with polyQ fragments, DNAJB6 and DNAJB8 reduce polyQ protein aggregation and may be
potential therapeutic targets in polyQ disorders.
Fragments of proteins containing an expandedpolyglutamine
(polyQ) tract are thought to initiate aggregation and toxicity in
at least nine neurodegenerative diseases, including Hunting-
ton’s disease. Because proteasomes appear unable to digest the
polyQ tract,which can initiate intracellular protein aggregation,
preventing polyQ peptide aggregation by chaperones should
greatly improve polyQ clearance and prevent aggregate forma-
tion. Here we expressed polyQ peptides in cells and show that
their intracellular aggregation is prevented by DNAJB6 and
DNAJB8, members of the DNAJ (Hsp40) chaperone family. In
contrast,HSPA/Hsp70 andDNAJB1, alsomembers of theDNAJ
chaperone family, did not prevent peptide-initiated aggrega-
tion. Intriguingly, DNAJB6 and DNAJB8 also affected the
soluble levels of polyQ peptides, indicating that DNAJB6
and DNAJB8 inhibit polyQ peptide aggregation directly.
Together with recent data showing that purified DNAJB6 can
suppress fibrillation of polyQ peptides far more efficiently
than polyQ expanded protein fragments in vitro, we conclude
that the mechanism of DNAJB6 and DNAJB8 is suppression
of polyQ protein aggregation by directly binding the polyQ
tract.
Polyglutamine (polyQ)3 disorders are a group of dominantly
inherited, progressive neurodegenerative disorders. These dis-
orders are caused by expansion of the polyQ tract within coding
regions of unrelated proteins. At least nine different polyQ dis-
orders are known, including Huntington´s disease (1). These
disorders are characterized by atrophy of certain regions in the
brain and the presence of intracellular aggregates that are
thought to initiate disease, although neither the precise toxic
species nor the cause of aggregation initiation are fully under-
stood. Several studies showed that these aggregates contained
not only the full-length disease-related protein but also short-
ened fragments, including the expanded polyQ tract (2–4).
Furthermore, it was shown that truncated forms of huntingtin
(Htt), ataxin 3, ataxin 7, atrophin 1, and the androgen receptor
containing the expanded polyQ tract, are more aggregation-
prone and enhance toxicity (5–11). Although proteasomes are
able to degrade polyQ-containing proteins (12–15), they may
not be able to cleave within polyQ tracts in vitro (16). As a
consequence, polyQ peptides may be released upon protea-
somal degradation of expanded polyQ proteins. Similar polyQ
peptides may be directly generated in related disorders, such as
SCA8 and Huntington’s disease like-2 (HDL2), which are
thought to be initiated by polyQ peptides generated by anti-
sense transcription that cause intranuclear inclusions (9, 17).
When mimicking polyQ peptide generation in living cells, we
observed that expression of expanded polyQ peptides is suffi-
cient to induce aggregation and toxicity in cells (18) and that
expression of polyQ stretches alone causes toxicity inDrosoph-
ila (19).
Aggregates or inclusion bodies initiated by expanded polyQ
peptides as well as expanded polyQ-containing proteins are
decorated with various proteins, such as components of the
ubiquitin-proteasome system and heat shock proteins (HSP)
(20–26). HSPs can function as molecular chaperones. Many of
them are up-regulated under stress conditions, such as heat
stress (27, 28), and have been shown to protect cells against
heat-induced protein aggregation (29, 30). Heat shock proteins
can be classified into a number of families on the basis of their
approximate molecular mass and presence of conserved
domains (31, 32). The HSPA (Hsp70) family consists of 11
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members, whereas theDNAJ (Hsp40) family consists of over 40
members in humans (32). In a recent comparative screen of all
members of the HSPA, HSPH (Hsp110), and DNAJ (sub)fami-
lies, DNAJB6 and DNAJB8 were identified as the two most
potent suppressors of aggregation and related toxicity of
expanded polyQ proteins (33). When examining the charac-
teristics of these two chaperones in more detail, we now find
that DNAJB6 and DNAJB8 can directly suppress aggregation
of polyQ peptides generated in living cells. This action is
largely dependent on the serine-rich region (SSF-SST)
within the C terminus and less dependent on interaction
with Hsp70. Intriguingly, expression of DNAJB6 in the
nucleus also represses aggregation in the cytoplasm, suggest-
ing that polyQ peptides are kept solubilized in one cellular
compartment by these chaperones and remain small enough
to travel to the other compartment for subsequent degrada-
tion. The ability of DNAJB6 and DNAJB8 to reduce aggrega-
tion of expanded polyQ peptides prevents these polyQ pep-
tides from acting as inducers of aggregation and improves
their clearance.
EXPERIMENTAL PROCEDURES
DNA Constructs—Generation of GFP-Ub-polyQ constructs
was described before (18). However, the initial polyQ peptides
started with a Leu residue and a Glu-Thr-Ser-Pro-Arg se-
quence at the C terminus. This Leu residue was changed into a
Gln using QuikChange II site-directed mutagenesis (Strat-
agene). At theC terminus, a stop codonwas introduced directly
after the polyQ stretch using site-directed mutagenesis, result-
ing in GFP-Ub-Q16 and GFP-Ub-Q104, respectively. To insert
a tetracysteine (C4) tag after the polyQ tract, a BamHI site was
introduced at theN terminus of polyQ peptides usingGFP-Ub-
Q16/112,where Leuwas already changed into aGln. TheC4 tag
containing the sequence FLNCCPGCCMEP (34) was obtained
by annealing two encoding oligo primers with overhangs com-
patible with BamHI at the N terminus and XbaI at the C termi-
nus. A C4 tag was inserted into GFP-Ub-polyQ using BamHI
and XbaI, thereby generating GFP-Ub-Q17-C4 and GFP-Ub-
Q99-C4, respectively.
Plasmids encoding DNAJB6a, DNAJB6b (including H31Q),
and DNAJB8 (including H31Q and SSF-SST) in pcDNA5
FRT/TO V5 vectors were described before (33) and were sub-
sequently cloned into either pIRES-DsRed2 (Invitrogen) to
generate untagged chaperones or into tagRFP (Evrogen) to
generate chaperonesN-terminally tagged with red fluorescent
protein. DNAJB6b SSF-TST was generated by deleting
amino acids 155–195 within DNAJB6b. Htt-exon1-Q103-
GFP was provided by Ron Kopito (Stanford University, Stan-
ford, CA), and HSPA1A-GFP was provided by Harm Kamp-
inga (UniversityMedical Center Groningen, Groningen, The
Netherlands).
Cell Culture andTransfection—HEK293 cells and the human
melanoma cell lineMel Juso were cultured in Iscove’s modified
Dulbecco’s medium (Invitrogen) supplemented with 10% FCS,
25mMHepes, 100 units/ml penicillin, 100g/ml streptomycin,
and 1 mM glutamine (Invitrogen). HeLa cells were cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen) supple-
mented as described above. HeLa and Mel Juso cells (0.15 
106) were plated onto glass coverslips (24mm, Fisher Scientific)
in a 6-well plate and were transiently transfected using
FuGeneHD (Roche) 24 h after plating. HEK293 cells (0.1 106)
were seeded in 6-well plates and transiently transfected with
polyethylenimine (Polysciences) 24 h after plating.
siRNA Transfection—24 h after seeding, cells were trans-
fected with 50 nM control siRNA or DnaJb6 siRNA, repeated
48 h after seeding with 50 nM control siRNA or DnaJb6
siRNA together with 2.5 g of plasmid (48-h protein expres-
sion). Transfections were done with Lipofectamine 2000
(Invitrogen) and Dharmacon SMARTpool siRNA siGenome
DNAJB6 (M-013020-00-0005) and non-targeting siRNA con-
trol siGENOME (D-001206-13-20).
Biarsenical Labeling—HeLa cells were transfectedwithGFP-
Ub-Q99-C4 and DNAJB6 or DNAJB8, and biarsenical labeling
was performed 72 h after transfection, as described before (34).
Briefly, 1 mM ReAsH was preincubated in 10 mM 1,2-ethanedi-
thiol (Sigma) inDMSO for 10min. Cells were labeledwith 1M
ReAsH in 10 M 1,2-ethanedithiol in OptiMEM for 45 min at
37 °C, 10% CO2 in the dark and subsequently washed several
times with 1 mM 1,2-ethanedithiol in OptiMEM containing
10% FCS for 30 min at room temperature to remove unbound
dyes.
Confocal and FRET-FLIMMicroscopy—HEK293T cells were
cotransfected with GFP-Ub-polyQ and various chaperones, as
indicated in the figure legends, and the percentage of aggregate-
positive cells was determined after 72 h. The number of cells
containing aggregates in the nucleus, cytoplasm, or both com-
partments was determined 48 and 72 h after transfection. Con-
focal microscopy images were obtained 48 h after transfection
using a Leica SP2 confocal system equippedwith anAr/Kr laser
with a 63 objective. For fluorescence loss in photobleaching
analysis, either a part of the cytoplasm or the whole cell, except
for the aggregate, was repeatedly photobleached at full laser
power. Fluorescence loss was measured either within the
nucleus or within the non-bleached region containing the
aggregate, respectively. For fluorescent recovery after photo-
bleaching analysis, fluorescently tagged chaperones trapped in
polyQ peptide-induced aggregates were bleached at full laser
power, and fluorescence recovery was measured in time. FLIM
was carried out after biarsenical labeling of living cells. To
reduce interference of autofluorescence by DMEM, a special
medium was added to cells (20 mM Hepes (pH 7.4), 137 mM
NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, and 20 mM
glucose). FLIM was performed using the wide-field frequency
domain approach on a home-built instrument (35) using a radi-
o-frequency-modulated image intensifier (Lambert Instru-
ments, model no. II18MD) coupled to a CCD camera (Photo-
metrics HQ) as a detector. A  40 objective was used for all
measurements. The modulation frequency was set to 75.1
MHz. Eighteen phase images with an exposure time of 20–200
ms were acquired in a random recording order to minimize
artifacts because of photobleaching (36). From the phase
sequence, an intensity image and the phase and modulation
lifetime image were calculated using Matlab macros. From this
data, the lifetime of individual cells was determined. Subse-
quently, average phase and modulation lifetimes ( S.D.) were
calculated. The FRET efficiency (E) was calculated according to
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the following: E  (1  (DA/D))  100%, in which DA is the
fluorescence lifetime of the donor in the presence of the accep-
tor (i.e. samples labeled with both FlAsH or GFP and ReAsH)
and D is the fluorescence lifetime of the donor (i.e. FlAsH only
or GFP only) in the absence of the acceptor. Frequency domain
FLIM yields a phase lifetime () and a modulation lifetime
(M). Because  is more sensitive than M, FRET efficiency was
calculated on the basis of .
Immunoblotting—Cells were trypsinized and lysed in lysis
buffer (50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA,
1% Triton X-100). Total cell lysates were boiled for 10 min at
99 °C with 1 Laemmli sample loading buffer (350 mM Tris/
FIGURE1.DNAJB6andDNAJB8 reduceaggregationofexpandedpolyQpeptides.A, schematic representationof the cleavageofGFP-Ub-polyQconstructs
by Ub C-terminal hydrolases directly after Ub, thereby separating GFP-Ub and polyQ. B, the percentage of the fluorescent HEK293 cells that contained
fluorescent aggregates at 72 h after transfectionwith GFP-Ub-Q104 in combinationwith DNAJB6a, DNAJB6b, DNAJB8, HSPA1A, or DNAJB1, respectively. Data
aremean S.E. of three independent experiments (two-tailedunpaired Student’s t test). *,p0.05; ***,p0.001;ns, not significant.C, SDS-insoluble fractions
prepared 72 h after transfection with the indicated constructs and analyzed by filter trap analysis. Blots were stained for polyQ using 1C2 antibody. Data are
mean S.E. of three independent experiments (two-tailed unpaired Student’s t test). **, p 0.01; ***, p 0.001. D, expression levels of the GFP or dsRED-
tagged chaperones coexpressed with Ub-Q104 in HEK293 cells for 72 h. Nomolecular weight marker is present because the fluorescence of the proteins was
measured directly. E, upper panel, knockdown of DNAJB6 increases aggregation in cells expressing Ub-Q104, as analyzed by filter trap analysis 72 h after
transfection. Lower panel, knockdown of DNAJB6 by siRNA leads to a reduction in endogenous DNAJB6 levels. Data are mean  S.E. of three independent
experiments (two-tailed unpaired Student’s t test). *, p 0.05; ***, p 0.001.
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HCl (pH 6.8), 10% SDS, 30% glycerol, 6% -mercaptoethanol,
bromphenol blue), fractionated by SDS-PAGE gel electropho-
resis, and transferred to a PVDFmembrane (0.45-mpore size,
Schleicher & Schuell). Membranes were blocked with 5% milk,
incubated with primary antibodies (anti-polyQ 1C2, 1:1000,
Millipore, catalog no. MAB1574), polyclonal rabbit anti-GFP
(1:1000, provided by J. Neefjes, NKI, The Netherlands), and
anti--actin (1:1000, Santa Cruz Biotechnology, Inc., catalog
no. SC-130656) and subsequently incubated with secondary
antibodies (IRDye 680 or IRDye 800, 1:10,000, Licor Biosci-
ences). The infrared signal was detected using the Odyssey
imaging system (Licor Biosciences). Soluble and insoluble frac-
tionation was performed as described before (37). Briefly,
cells were lysed in 1 TEX buffer (70 mM Tris/HCl (pH 6.8),
1.5% SDS, 20% glycerol). After sonification, 50 mM DTT was
added, and samples were centrifuged at 14,000 rpm at room
temperature. The pelleted fraction was incubated with 100%
formic acid at 37 °C for 40 min and evaporated by using a
speedvac system (Eppendorf). 1 TEX buffer supplemented
with 0.05% bromphenol blue was added to the pellet, and the
soluble and insoluble fractions were loaded on an SDS-
PAGE gel.
Filter Trap Assay—The filter retardation assay was per-
formed as described before (38). Briefly, HEK293T cells
expressing GFP-Ub-Q65 together with DNAJB6b or DNAJB8
for 72 h incubated with the various inhibitors were lysed for 30
min on ice in Nondinet P-40 (Nonidet P-40) buffer (100 mM
TrisHCl (pH 7.5), 300 mM NaCl, 2% Nonidet P-40, 10 mM
EDTA (pH 8.0) supplemented with complete mini protease
inhibitor mixture (Roche) and phosphatase inhibitor mixture
(Sigma). After 15 min of centrifugation at 14,000 rpm at 4 °C,
cell pellets were resuspended in benzonase buffer (1mMMgCl2,
50 mM Tris-HCl (pH 8.0)) and incubated for 1 h at 37 °C with
250U benzonase (Merck). Reactions were stopped by adding
2 termination buffer (40 mM EDTA, 4% SDS, 100 mM
DTT). Aliquots of 30 g of protein extract were diluted into
2% SDS buffer (2% SDS, 150 mM NaCl, 10 mM Tris (pH 8.0))
and filtered through a 2-m cellulose acetate membrane
(Schleicher & Schuell) pre-equilibrated in 2% SDS buffer.
Filters were washed twice with 0.1% SDS buffer (0.1% SDS,
150 mM NaCl, 10 mM Tris (pH 8.0)) and subsequently
blocked in 5% dry milk in TBS. Captured aggregates were
detected by incubation with 1C2 antibody and further
treated like Western blot analyses.
FIGURE 2. DNAJB6 and DNAJB8 reduce insoluble levels of expanded polyQ peptides and Htt-exon-1. A, SDS-soluble and SDS-insoluble fractions
prepared 24 h after transfection with GFP-Ub-Q104 in combination with DNAJB6b and DNAJB8 and analyzed byWestern blotting. Blots were stained for
polyQ using 1C2 antibody and anti-actin antibody. The arrows indicate specific Glu-104 peptide bands that are quantified together in the lower panel.
Data are mean  S.E. of three independent experiments (two-tailed unpaired Student’s t test). **, p  0.01; ***, p  0.001; ns, not significant.
B, SDS-soluble and SDS-insoluble fractions prepared 72 h after transfection with Htt-exon-1-Q103-GFP in combination with DNAJB6b and DNAJB8 and
analyzed by Western blotting. The blots were stained for polyQ using 1C2 antibody (upper panel), anti-GFP antibody (center panel), and anti-actin
antibody (lower panel).
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RESULTS
DNAJB6b and DNAJB8 Reduce Aggregation of PolyQ Pep-
tides—To determine the effect of chaperones on polyQ peptide
aggregation in living cells, we usedGFP-ubiquitin-polyQ (GFP-
Ub-polyQ) constructs that are immediately cleaved upon
expression into GFP-Ub and polyQ peptides by Ub C-terminal
hydrolases (Fig. 1A) (39). The resulting polyQ peptides lack any
flanking amino acids, such as a starting methionine, and only
expanded polyQpeptides beyond 40 glutamines induced aggre-
gation, as quantified by the sequestration of GFP-Ub into
aggregates (18). Although 60% of cells expressing Glu-104
peptides contained aggregates after 72 h, coexpression of
HSPA1A (Hsp70) had no significant effect on polyQ peptide
aggregation, whereas DNAJB1 (Hsp40) slightly reduced aggre-
gation (Fig. 1B). In contrast, coexpression of DNAJB6b or
DNAJB8 resulted in a dramatic decrease in polyQ peptide aggre-
gationwhen scoring the number of polyQ-expressing cells having
aggregates (Fig. 1B) or by filter trap analysis (C)when similar levels
of the different chaperones were expressed (D). In contrast, when
endogenous DNAJB6 levels were decreased by siRNA (Fig. 1E,
lowerpanel), aggregationofpolyQpeptides increased, as indicated
by filter trap analysis (upper panel).
To examine whether expression of DNAJB6b and DNAJB8
also reduced the amount of SDS-insoluble polyQ aggregates,
cells expressing GFP-Ub-polyQ in combination with
DNAJB6b or DNAJB8 were separated into SDS-soluble and
SDS-insoluble fractions. Expression of Glu-104 peptides for
24 h resulted in a specific polyQ-positive band in the soluble
and various bands in the insoluble fractions (Fig. 2A, arrows).
Coexpression of DNAJB6b and DNAJB8 remarkably reduced
the amount of polyQ peptides present in the SDS-insoluble
fraction (Fig. 2A, right panel), which is in agreement with the
reduced number of aggregates visualized in cells. Interest-
ingly, the soluble fraction of Glu-104 peptides increased,
(Fig. 2A, left panel), suggesting that DNAJB6b and DNAJB8
keep polyQ peptides soluble. To examine whether the
SDS-soluble fraction was a precursor of one of the insoluble
polyQ peptide fractions, we separated fractions at different
time points after transfection. Both the soluble and insoluble
fraction decreased when cells were treated with cyclo-
heximide to block synthesis of new polyQ peptides during
the last 16 h, suggesting that the soluble fraction was not a
precursor to a particular insoluble fraction (data not
shown).
FIGURE 3. Tetracysteine (C4)-tagged polyQ peptides behave similarly as non-labeled polyQ peptides. A, the percentage of HEK293 cells containing
aggregates 72 h after transfection with GFP-Ub-Q16/Q104 or C4-tagged GFP-Ub-Q17/Q99. Data are mean S.E. of three independent experiments. Similar
amounts of aggregates were detected with either non-tagged or C4-tagged polyQ peptides. B, SDS-soluble and SDS-insoluble fractions prepared 24 h after
transfection of HEK293 cells with Ub-Q99-C4 in combination with DNAJB6b and DNAJB8 and analyzed by Western blotting. The blots were stained for polyQ
(1C2) and actin. The arrows indicate specific Glu-104 peptide bands. C, SDS-insoluble fractions of HEK293 cells expressing GFP-Ub-Q16/Q104 or C4-tagged
GFP-Ub-Q17/Q99 prepared 24 h after transfection were stained for polyQ. D, confocal microscopy images of ReAsH-labeled HeLa cells expressing C4-tagged
GFP-Ub-Q17 or GFP-Ub-Q99 48 h after transfection. ReAsH-positive cells were detected only when polyQ-expanded C4-tagged Glu-99 peptides were
expressed (lower panel). The inset shows a GFP-Ub-decorated aggregate. Scale bar 10 m.
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SDS-insoluble levels of Htt-exon1-Q103 were also
decreased by coexpression of DNAJB6b or DNAJB8 (Fig. 2B,
right panel). In contrast to polyQ peptides, the SDS-soluble
Htt-exon1-Q103 protein levels were not affected (Fig. 2B,
left panel). The observed decrease in insoluble Htt-exon-1
could, however, indicate that DNAJB6b and DNAJB8 can
DNAJB6 and DNAJB8 Prevent PolyQ Peptide Aggregation
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improve solubility and clearance of Htt-exon-1, as shown
before (33, 40).
DNAJ6b and DNAJB8 Are Recruited into PolyQ Peptide
Aggregates—To examine the effect of DNAJB6b and DNAJB8
with polyQpeptides inmore detail, polyQpeptides were tagged
with the small tetracysteine (C4) motif FLNCCPGCCMEP at
the C terminus for direct visualization. Themembrane-perme-
able biarsenical dye ReAsH can bind this small tag, and only
then does it becomes fluorescent (34). To examine whether the
C4 tag affected the behavior of polyQ peptides, we transiently
expressed GFP-Ub-polyQ and GFP-Ub-polyQ-C4 peptides.
Expression of either C4-tagged or non-tagged polyQ peptides
resulted in a similar percentage of fluorescent cells that con-
tained aggregates after 72 h (Fig. 3A). Similar to untaggedQ104
peptides, DNAJB6b and DNAJB8 kept Glu-99-C4 SDS-soluble
(Fig. 3B), and similar SDS-insoluble fractions were detected
between cells expressing untagged Glu-104 or C4-tagged
Glu-99 peptides (C). In cells without aggregates, both GFP-Ub
and expanded polyQ peptides were present throughout the
cytoplasm and nucleus (Fig. 3D, upper panel). However, aggre-
gation led to the redistribution of both GFP-Ub and ReAsH-
labeled Glu-99-C4, with ReAsH-labeled Glu-99-C4 seques-
tered in the core of aggregates andGFP-Ub in a ring around the
core (Fig. 3D, lower panel, also in the inset). Only C4-tagged
polyQ peptides of disease-related lengths accumulated and ini-
tiated aggregation, whereas short C4-tagged polyQ peptides
were degraded similarly to untagged polyQ peptides.
PolyQ Peptides Sequestered in Aggregates Strongly Interact
with DNAJB6b and DNAJB8—To examine whether diffuse and
aggregated polyQ peptides showed intermolecular interac-
tions, we performed FRET experiments. FRET enables sensitive
evaluation of protein-protein interactions in living cells. Only
whenproteins are in close proximity ( 10nm) can FREToccur
and be measured (41). FLIMwas used to measure FRET-FLIM,
which is detected as a decrease in donor fluorescence lifetime
(42). HeLa cells expressing Ub-Q99-C4 were labeled simulta-
neously with equal amounts of FlAsH and ReAsH at 48 h after
transfection, leading to individual labeling of polyQ peptides
with either FlAsH or ReAsH. When polyQ peptides were not
clustered in aggregates, no reduction in FlAsH lifetime was
measured (Fig. 4A), suggesting that polyQ-polyQ peptide inter-
actions hardly occurred when not sequestered in aggregates. In
contrast, aggregated polyQ peptides showed a remarkable
decrease in lifetime of 39.6% of FlAsH, which is indicative of
FRET (Fig. 4A). Together, these data show that polyQ peptides
aremainlymonomericwhennot present in aggregates, whereas
aggregated polyQ peptides are immobile, and only then strong
polyQ-polyQ peptide interactions are observed.
The presence of GFP-Ub in aggregatesmost likely represents
sequestered proteins that become ubiquitinated in time,
whereas the polyQpeptides are not likely ubiquitinated because
no lysine residues are present. Because expression of GFP-Ub-
Q99-C4 results in an efficient separation of GFP-Ub and Glu-
99-C4, cells expressing either GFP-Ub-Q99-C4 or GFP-Ub
combined with Ub-Q99-C4 should hardly show interactions
between polyQ peptides and GFP-Ub (Fig. 4B). The recruit-
ment of proteasomes into the core of polyQ peptide-initiated
aggregates suggests that proteasomes interact with the polyQ
peptides. To substantiate this idea, cells were cotransfected
with Ub-Q99-C4 and the GFP-tagged proteasomal component
7. Coexpression of ReAsH-labeled Glu-99-C4 with the GFP-
tagged proteasomal component 7 caused a decreased lifetime
of GFP (Fig. 4B), indicating a direct interaction with the polyQ
peptides. In the few cells that showed aggregates upon
DNAJB6b or DNAJB8 coexpression, these chaperones were
present in the core of aggregates (Fig. 4C). Therefore, we exam-
ined whether these chaperones also interact with aggregated
polyQ peptides. Both GFP-tagged DNAJB6b and DNAJB8
interacted stronglywith polyQpeptides, as shownby the reduc-
tion in lifetime (Fig. 4D). In contrast, the recruitment of Hsp70
into polyQ peptide-induced aggregates did not result in a sig-
nificantly reduced lifetime of GFP-tagged Hsp70 (Fig. 4D), sug-
gesting thatHsp70 does not interactwith polyQpeptides. Thus,
most proteins that sequester in the core of aggregates, such as
7, DNAJB6b, and DNAJB8, interacted with aggregated polyQ
peptides. This suggests that in the rare event of aggregation
whenDNAJB6b andDNAJB8 are coexpressed, they are trapped
into aggregates induced by polyQ peptides in an early stage,
which may reflect a failed function of these chaperones.
The Serine-rich Region in DNAJB6 and DNAJB8 Is Essential
for Reduction of Aggregation—The DNAJ family is defined by
the presence of a J domain that can regulate chaperone activity
of theHSPA family by stimulating ATP hydrolysis (Fig. 5A) (43,
44). The HPD sequence in the J domain is essential for interac-
tion with and accelerating the ATPase activity of HSPA (45).
The other domains of DNAJ family members are involved in
recognition and binding of clients and are considered to be a
main factor in driving the specificity of Hsp70 machines (46).
Mutating His to Glu (H31Q) in the HPD motif results in an
inactive J domain (45), but this only partly impaired the ability
of DNAJB6 and DNAJB8 to reduce polyQ peptide aggregation
as scored by the amount of fluorescent cells having aggregates
FIGURE 4. The chaperones DNAJB6b andDNAJB8 interact with aggregated polyQ peptides. A, FLIM analysis of FlAsH in HeLa cells expressing Ub-Q99-C4
labeled with either FlAsH alone or both with FlAsH and ReAsH showing in each column, from left to right, representative graphs of fluorescence intensity, a
false-color map of the fluorescence lifetime calculated from the phase shift (), and a histogram of the lifetime distribution with the same false-color scale as
the lifetimemap. The histogram represents average phasemodulation lifetimes. Only aggregated polyQ peptides showed high FRET-FLIM efficiencies. ns, not
significant. Data are mean  S.E. (two-tailed unpaired Student’s t test). ***, p  0.001; ns, not significant. B, FLIM analysis of GFP in HeLa cells expressing
ReAsH-labeled Ub-Q99-C4 together with the indicated GFP-tagged constructs 48 h after transfection. The histogram represents average phase modulation
lifetimes. FLIM analysis resulted in high FRET-FLIM efficiencies between aggregatedGlu-99-C4 peptides and the proteasomal subunit7. Data aremean S.E.
(two-tailed unpaired Student’s t test). *, p  0.05; **, p  0.01; ***, p  0.001; ns, not significant. C, confocal microscopy images of HeLa cells expressing
ReAsH-labeled Glu-99-C4 in combination with GFP-tagged DNAJB6a, DNAJB6b, or DNAJB8, which are all present in the core of the aggregate. Red
fluorescent protein-tagged DNAJB1 is not recruited into aggregates, whereas red fluorescent protein-tagged HSPA1A is only recruited to the outside of
the aggregate. Scale bar 10m.D, FLIM analysis of GFP in cells expressing ReAsH-labeled Ub-Q99-C4 together with indicated GFP-tagged chaperones
48 h after transfection. FLIM analysis resulted in high FRET-FLIM efficiencies between aggregated polyQ peptides and DNAJB6b and DNAJB8. No
FRET-FLIM was detected between aggregated polyQ peptides and Hsp70. Data are mean S.E. (two-tailed unpaired Student’s t test). ***, p 0.001; ns,
not significant. Scale bar 10 m.
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(Fig. 5B). The H31Q mutants also still reduced the appearance
of polyQ peptides on a filter trap (Fig. 5C) as well as in the
SDS-insoluble fraction (D). However, the SDS-soluble fraction
was also decreased (Fig. 5E), indicating that the J domain is
somewhat affecting DNAJB6 and DNAJB8 function, albeit that
their main antiaggregation function is intact, consistent with
was found before for preventing the aggregation of htt-exon-1
fragments (33).
In the C-terminal region of DNAJB6b and DNAJB8, a con-
served serine-rich region (SSF-TST and SSF-SST, respectively)
is present, which is absent in DNAJB1 or its related subfamily
members (Fig. 5A) (47). Deletion of this serine-rich region was
found to be crucial for DNAJB6 and DNAJB8 to interact with
histone deacetylases that regulate their function as suppressors
of expanded polyQ protein aggregation (33). Deletion of this
serine-rich region also severely affected the ability of DNAJB6
and DNAJB8 to reduce polyQ peptide aggregation (Fig. 5B),
resulting in more SDS-insoluble material on a filter trap (Fig.
5C) and Western blot analysis (D) and a reduction in SDS-
soluble levels (E). The defective chaperones were still recruited
into polyQ peptide aggregates, but these sequestered chaper-
ones lost their direct interaction with the labeled polyQ pep-
tides once the serine-rich region was disabled (Fig. 5F). This
suggests that the sequestration of both functional and disabled
DNAJB6 and DNAJB8 may not be their primary way of inter-
fering with aggregation but, rather, reflect an inefficient
attempt to prevent aggregate initiation and growth.
Because DNAJB6 and DNAJB8 strongly reduce aggregation
of polyQ peptides and interact with polyQ peptides in the core
of aggregates, these interactions may affect aggregation of
polyQ peptides directly. To examine whether chaperones were
able to reduce the strong interactions observed between polyQ
peptides, we coexpressed Glu-99-C4 peptides in combination
with DNAJB6, DNAJB8, Hsp40, or Hsp70. Double-labeling of
C4-taggedGlu-99 peptideswith FlAsH andReAsH resulted in a
high FRET-FLIM efficiency (Fig. 5G). Coexpression of
DNAJB6b or DNAJB8 hardly affected interactions between
aggregated polyQ peptides, indicating that the sequestration of
DNAJB 6 or DNAJB8 does not interfere with peptide interac-
tions within the aggregate. Similarly, Hsp40 andHsp70 did also
not affect the interactions between aggregated polyQ peptides.
NuclearDNAJB6aReduces Aggregation in theCytoplasmand
Nucleus—The effect of DNAJB6b on SDS-soluble levels of
polyQ peptides suggests that it may counteract very early olig-
omerization steps of these aggregation-prone peptides. To
examine this phenomenon in more detail, we reasoned that
only monomeric or small oligomers can shuttle freely through
the nuclear pore by diffusion. If correct, the presence of
DNAJB6 in the nucleus or cytoplasm only should then reduce
aggregation in both compartments by keeping the polyQ pep-
tides soluble. DNAJB6 has two isoforms. DNAJB6b is present in
both the cytoplasm and nucleus, whereas DNAJB6a contains a
putative nuclear localization signal and is, therefore, localized
in the nucleus only (Fig. 6A) (33). Despite the exclusive local-
ization of DNAJB6a in the nucleus, the expression of DNAJB6a
was as effective as DNAJB6b and DNAJB8 in reducing polyQ-
peptide aggregation (Fig. 1B). Interestingly, the reduction in
aggregate formation was not limited to the compartment were
these chaperones were residing. Coexpression of DNAJB8 did
not alter the ratio of nuclear and cytoplasmic aggregates after
48 h, whereas coexpression of DNAJB6b resulted in a slight
change in this ratio in favor of nuclear aggregates (Fig. 6B,upper
panel). Expression of DNAJB6b and DNAJB8 resulted in an
even higher percentage of aggregates present in nuclei after
72 h (Fig. 6B, lower panel). The nuclear localization of
DNAJB6a did not lead to the exclusive presence of aggregates in
the cytoplasm because the ratio of nuclear and cytoplasmic
aggregates remained unaltered after expression of DNAJB6a
(Fig. 6B). It is concluded that although DNAJB6a is present in
the nucleus only, it does not exclusively reduce aggregation in
the nuclear compartment.
Together, these data suggest that DNAJB6 and DNAJB8
are efficient in targeting earlier stages of aggregation, whereas
the observed recruitment of DNAJB6 and DNAJB8 into aggre-
gates reflects sequestration of these chaperones without any
effect on improved clearance. To examine whether DNAJB6a,
DNAJB6b, andDNAJB8were able to dissociate from the core of
aggregates, we studied the mobility of the sequestered chaper-
ones using fluorescent recovery after photobleaching and fluo-
rescence loss in photobleaching analysis (48, 49). Fluorescent
recovery was observed of HSPA1A but not of DNAJB6a,
DNAJB6b, and DNAJB8 (Fig. 6C). When the entire cell was
bleached repeatedly, with the exception of one fluorescent
aggregate, fluorescence loss in the aggregate was measured of
HSPA1A, whereas DNAJB6a, DNAJB6b, and DNAJB8 present
in the core of aggregates were hardly affected by bleaching (Fig.
6D). These data show that DNAJB6a, DNAJB6b, and DNAJB8
were sequestered irreversibly in the core of polyQ-induced
FIGURE 5. The serine-rich regionwithin DNAJB6 andDNAJB8 is essential for reduction of polyQ peptide-induced aggregation. A, schematic represen-
tation of domains present in DNAJB6a, DNAJB6b, and DNAJB8. NLS; nuclear localization signal. B, the percentage of fluorescent HEK293 cells that contained
aggregates 72 h after transfection with GFP-Ub-Q104 in combination with DNAJB6b or DNAJB8 and their J domain (H31Q) and serine-rich region mutants
(SSF-TST andSSF-SST, respectively). Data are mean S.E. of three independent experiments (two-tailed unpaired Student’s t test). *, p 0.05; **, p 0.01;
***, p  0.001. An inactive J domain induced a small increase in aggregation, whereas deletion of the serine-rich region severely increased aggregation of
Glu-104 peptides. C, SDS-insoluble fractions prepared 72 h after transfection of HEK293 cells with he indicated constructs and analyzed by filter trap analysis.
Theblotswere stained forpolyQusing1C2antibody.Data aremeanS.E. of three independent experiments (two-tailedunpairedStudent’s t test). **,p0.01;
***, p 0.001; ns, not significant.D, Western blot analysis of the SDS-insoluble fraction of HEK cells expressing GFP-Ub-Q104 in combinationwith DNAJB6b or
DNAJB8 and their mutants for 24 h. Western blot analyses were stained for polyQ with 1C2 antibody. The arrows indicate specific Glu-104 peptide bands. E,
Westernblot analysis of the SDS-soluble fractionofHEK293 cells expressingGFP-Ub-Q104 in combinationwithDNAJB6borDNAJB8 and theirmutants for 24h.
Western blot analyses were stained for polyQ with 1C2 antibody, anti-actin antibody (center panel), or anti-DNAJB6b/8 antibody (lower panel). The arrows
indicate specific Glu-104peptidebands. F, FLIManalysis of GFP-taggedDNAJB6b and the serine-rich regionmutant (upper panel) andGFP-taggedDNAJB8 and
the serine-rich region mutant (lower panel) in cells expressing ReAsH-labeled Ub-Q99-C4 48 h after transfection shows high FRET-FLIM efficiencies between
aggregatedpolyQpeptides andDNAJB6borDNAJB8, butmuch less FRET-FLIMwasdetectedbetween aggregatedpolyQpeptides and their serine-rich region
mutant counterparts. Data are mean S.E. (two-tailed unpaired Student’s t test). *, p 0.05; ***, p 0.001. Scale bar 10 m. G, DNAJB6 or DNAJB8 do not
reduce intermolecular interactions between aggregated polyQ peptides. The histogram represents average phasemodulation lifetimes of FlAsH in HeLa cells
expressing Ub-Q99-C4 together with the indicated constructs and labeled with both FlAsH and ReAsH 48 h after transfection.
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aggregates, indicating that once the activity of these chaperones
has failed to prevent aggregation, they are irreversibly trapped
in the inert core of aggregates.
DISCUSSION
Intracellular polyQ clearancemay be facilitated byHSPs that
prevent the formation of insoluble aggregation, allowing clear-
ance pathways involving proteases and autophagic pathways to
remove hazardous fragments. In this study, we examined
mechanisms to prevent aggregation of polyQ fragments, focus-
ing on expanded polyQ peptides that can initiate aggregation
and toxicity. We found that the DNAJ family members
DNAJB6 andDNAJB8were efficient suppressors of polyQ pep-
tide aggregation. Interestingly, detergent-soluble levels of
mutant Htt-exon-1 were not affected by DNAJB6, whereas the
level of soluble polyQpeptideswas increased.Apparently, these
chaperones prevent aggregation of polyQ peptides, leading to
improved clearance of polyQ peptides, whereas soluble Htt-
exon-1 is not affected. The solubilized polyQ peptidesmight be
more efficiently cleared than Htt-exon-1 fragments. Alterna-
tively, aggregation of Htt-exon-1 might be initiated by smaller
fragments derived from Htt-exon-1 that are subsequently tar-
FIGURE 6. DNAJB6 and DNAJB8 prevent aggregation of Glu-104 peptides by keeping them soluble. A, confocal microscopy images of HeLa cells
transfected with DNAJB6a, DNAJB6b, or DNAJB8, respectively, stained with Hoechst, and fixed 72 h after transfection. Scale bar  10 m. B, the ratio of
aggregates present in the cytoplasm, nucleus, or both compartments 72 h after transfection with GFP-Ub-Q104 in combination with DNAJB6a, DNAJB6b, or
DNAJB8, respectively, in Mel JuSo cells. Data are mean S.E. of three independent experiments. Chaperones did not specifically reduce aggregation in the
compartment where they reside. C, fluorescent recovery after photobleaching analysis shows that DNAJB6a, DNAJB6b, and DNAJB8 did not recover after
photobleaching, whereas HSPA1A fluorescent levels recovered. D, fluorescence loss of aggregates was measured using fluorescence loss in photobleaching
analysis by repetitive photobleaching of another part of the cytoplasm. Fluorescence loss of HSPA1A was observed, whereas fluorescent levels of DNAJB6a,
DNAJB6b, and DNAJB8 were not affected.
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geted by DNAJB6. In contrast to polyQ peptides, fluorescently
tagged, expanded polyQ proteins, such as Htt-exon1-GFP,
were not present in the core of aggregates but sequestered in a
ring around the aggregate (18, 25, 50–52). This suggests that
smaller fragments containing the polyQ tract initiate aggrega-
tion and that the original GFP-tagged polyQ proteins are
sequestered in a later stage. Still, it remains to be resolved
whether polyQ peptides are generated in cells that express
polyQ-expanded proteins, similar to in vitro conditions (16).
This will, however, be a challenging task because the generated
polyQ peptides will either be captured by DNAJB6 or DNAJB8
and/or degraded or initiate aggregation and subsequent
sequestration of the original polyQ protein. To address the first
option, we purified DNAJB6 from polyQ fragment-expressing
cells to detect putatively associated polyQ peptides. Although
we did find several peptide fragments associated with them,
suggesting they indeed could be “peptide chaperones,” polyQ
peptides could unfortunately not be detected because of the
limitations of polyQ analysis by mass spectrometry (data not
shown).
DNAJB6 and DNAJB8 are the first examples of HSPs that
reduce aggregation of pure polyQ peptides. Our data are sup-
ported by recent observations by the group of Cecilia Emanu-
elsson,4 who showed that purified DNAJB6 and DNAJB8 can
directly bind to and highly efficiently suppress polyQ peptide
fibrillation initiated by soluble, pure polyQ peptides. In fact,
DNAJB6 and DNAJB8 were better at suppressing fibrillation
when initiated by polyQ peptides than when initiated by Htt-
exon-1 fragments.4 Given that in cells the two DNAJB proteins
can prevent aggregation of Htt-exon-1 fragments (33) (this
work), this implies that although some HSPs (HSPA1 or
DNAJB1) might prevent sequestration of polyQ proteins into
aggregates, DNAJB6 and DNAJB8 reduce aggregation of
expanded polyQ peptides. Thereby they prevent that polyQ
peptides can act as nucleators of aggregation and subsequent
sequestering of larger polyQ-containing fragments, such as
Htt-exon-1. Consistent with this model, DNAJB6 and DNAJB8
were trapped in the core of aggregates together with polyQ
peptides, whereas expanded polyQ proteins and HSPA1A or
DNAJB1 were absent from the core. The recruitment of
HSPA1A to the outer ring of aggregates may, in fact, be due to
its recognition of sequestered, possibly unfolded proteins and
its attempt to solubilize these proteins. Indeed,HSPA1A, unlike
DNAJB6 and DNAJB8, was not trapped in these aggregates
(reflecting a failed function to prevent aggregate seeding) but
showed ahigh degree of dynamics at the aggregate ring (Fig. 6C)
(24). Together, this indicates that only DNAJB6 and DNAJB8
may be able to directly prevent aggregation of polyQ proteins
by directly interacting with the expanded polyQ repeat,
whereas most other chaperones are mostly preventing the
sequestration of other proteins in the aggregate. As a result,
improving the activity or protein levels of these DNAJB chap-
erones might delay or even prevent the aggregation of polyQ
fragments, enabling intracellular clearance pathways to target
and degrade these fragments.
DNAJB6 and DNAJB8 may keep polyQ fragments soluble,
whereby they may be maintained in a degradation-competent
state. It remains to be established whether these chaperones
can also control their degradation by targeting them to partic-
ular proteases, such as the proteasome or the puromycin-sen-
sitive peptidase (PSA), or toward autophagosomes. Intrigu-
ingly, the ability of nuclear DNAJB6a to reduce polyQ peptide
aggregation was not restricted to the nuclear compartment
because aggregation within the cytoplasm was reduced simi-
larly. This suggests that DNAJB6a keeps polyQ peptides in a
soluble intermediate, which allows these peptides to freely
translocate between the cytoplasm and nucleus. This is of
importance because the autophagicmachinery is present in the
cytoplasmic compartment only (53, 54). This may also explain
our observation that the ratio of cytoplasmic versus nuclear
aggregates decreased in time because cytoplasmic aggregates
may bemore efficiently cleared as compared with aggregates in
the nucleus.
Deletion of the serine-rich region within DNAJB6 and
DNAJB8 abolished the antiaggregation properties of these
chaperones. This suggests that this region is essential to recog-
nize polyQ peptides and to inhibit their aggregation. An active
J domain was less important for DNAJB6b and DNAJB8 anti-
aggregation properties, although it affected the soluble levels of
polyQ peptides. Because the J domain is known to interact with
HSPA1A and stimulates its ATPase activity (43, 44), DNAJB6
and DNAJB8 do not seem to require HSPA1A to reduce polyQ
peptide aggregation. Little is known about the function of the
serine-rich region in DNAJB6 and DNAJB8, although this
region is suggested to be involved in DNAJB6/8 oligomeriza-
tion and histone deacetylase binding (33). Also, purified
DNAJB6 and DNAJB8 form large polydispersed oligomers,4
whichmight be crucial for efficient polyQ peptide binding. Pre-
vious studies showed that DNAJB6 is highly enriched in the
central nervous system (40, 47) and colocalizes to Lewy bodies
and aggregates induced by Htt-exon-1 (40, 55). However,
expression ofDNAJB8 is restricted to the testes (47). Therefore,
DNAJB6 may be the best candidate for potential therapeutic
approaches in the fight against polyQ disorders, for example by
inducing endogenous DNAJB6 expression. A combination of
solubilizing polyQpeptides by expression ofDNAJB6 and stim-
ulating their subsequent degradation seems to be the most
attractive alternative.
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